Molecular and Cell Biology of Human Gene Therapeutics: 20 (Molecular and Cell Biology of Human Diseases Series, 20) - Image 1

£128.00

Springer Molecular and Cell Biology of Human Gene Therapeutics: 20 (Molecular and Cell Biology of Human Diseases Series, 20)

Name: Molecular and Cell Biology of Human Gene Therapeutics: 20 (Molecular and Cell Biology of Human Diseases Series, 20)
Brand: Springer
Price: 128.0 GBP
Availability: InStock

Diseases & Disorders

It has never been this cheap. We have no record of a lower price.

£128 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 47 days · 47 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 47 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £130 (36 days, 76.6%)

Price range: £128 - £130

Price levels: 3 different prices over 47 days

Description

advanced metastatic disease of solid tumors, dictates that each tumor mass, indeed each individual metastasis, will have a unique antigen and cytokine environment and hence unique response to immune modu lation. A differential response to immunotherapy is thus inevitable. 4. Many of the human trials described are not randomized and report survival or response against historical controls. Most tumors described are immunogenic human tumors: renal cell cancer and melanoma are most common. In order to avoid the well-described inter-patient vari ation and rare incidence of spontaneous response among patient samples as well as selection bias and changes in practice over time, randomized trials are required. 5. Immunological treatment is unlike conventional chemotherapy in its endpoint. Most chemotherapeutic regimes require a complete response or a good partial response for cure or good palliation. There are now many cases where immunotherapy has provided long-term palliation without massive tumor reduction. Immunity may be stimulated to a degree which holds tumorigenicity in check and most importantly, pro vides good palliation for the patient in a manner that differs essentially from chemotherapy.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0412625504
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 31 May 1995
Listed Since: 16 February 2007

Barcode

No barcode data available

Springer Molecular and Cell Biology of Human Gene Therapeutics: 20 (Molecular and Cell Biology of Human Diseases Series, 20)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Experimental and Applied Immunotherapy

Monoclonal Antibody Therapy of Human Cancer: 38 (Developments in Oncology, 38)

Experimental and Applied Immunotherapy

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Brain Tumor Immunotherapy

Cancer Immunology and Immunotherapy: 344 (Current Topics in Microbiology and Immunology, 344)

Immunotherapy for Gastrointestinal Cancer

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Clinical Management of Malignant Melanoma: 21 (Cancer Treatment and Research, 21)

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Immunotherapy for Pediatric Malignancies

Malignant Melanoma: Biology, Diagnosis, and Therapy: 43 (Cancer Treatment and Research)

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Chemokines and Cancer (Contemporary Cancer Research)

Cancer Immunology: 30 (Immunology and Medicine, 30)

Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

NK Cells in Cancer Immunotherapy: Successes and Challenges (Volume 4) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 4)

Cancer Immunotherapy: Paradigms, Practice and Promise

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Immuno-Oncology: From Bench to Bedside

Innate and Adaptive Immunity in the Tumor Microenvironment: 1